Abivax SA American Depositary SharesABVX

Capital at risk.

About Abivax SA American Depositary Shares
Ticker
info
ABVX
Trading on
info
NASDAQ
ISIN
info
US00370M1036
Industry
info
Biotechnology
Sector
info
Healthcare
CEO
info
Marc M. P. de Garidel M.B.A.
Headquarters
info
7-11 Boulevard Haussmann, Paris, undefined, France, 75009
Employees
info
69
Website
info
abivax.com
ABIVAX Société Anonyme, a clinical-stage biotechnology company, develops therapeutics that harness the body's natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. Its lead drug candidate includes obefazimod, which is in Phase 3 clinical development for the treatment of moderately to severely active UC, as well as Phase 2b clinical trials for Crohn's disease. The company was incorporated in 2013 and is headquartered in Paris, France.
Metrics
BasicAdvanced
Market cap
info
$9.67B
P/E ratio
info
-
EPS
info
-$5.69
Dividend Yield
info
0.00%
Beta
info
-0.19
Forward P/E ratio
info
0
EBIDTA
info
$-245M
Ex dividend date
info
-
Price & volume
Market cap
info
$9.67B
Average daily volume
info
0.8M
90-day return
info
-
30-day return
info
-
7-day return
info
-
Dividends
Dividend per share
info
$0.00
Dividend yield
info
0.00%
Forward dividend per share
info
$0.00
Forward dividend yield
info
0.00%
Payout ratio
info
0.00%
Valuation
P/E ratio
info
0
Forward P/E
info
0
PEG ratio
info
-
Trailing P/E
info
0
Price to sales
info
2,115.18
Price to book
info
18.2
Earnings
EPS
info
-$5.69
EPS estimate (current quarter)
info
-$0.70
EPS estimate (next quarter)
info
$0.00
EBITDA
info
$-245M
Revenues (TTM)
info
$4.6M
Revenues per share (TTM)
info
$0.07
Technicals
Beta
info
-0.19
52-week High
info
$148.83
52-week Low
info
$5.59
50-day moving average
info
$117.02
200-day moving average
info
$106.43
Short ratio
info
2.89
Short %
info
3.25%
Management effectiveness
ROE (TTM)
info
-135.58%
ROA (TTM)
info
-38.95%
Profit margin
info
0.00%
Gross profit margin
info
$4.6M
Operating margin
info
-3,743.37%
Growth
Quarterly earnings growth (YoY)
info
0.00%
Quarterly revenue growth (YoY)
info
-55.40%
Share stats
Outstanding Shares
info
79.3M
Float
info
64.1M
Insiders %
info
-
Institutions %
info
79.68%
Analyst Insights & forecasts
info

86% Buy

14% Hold

0% Sell

Based on information from 7 analysts.

Average price target

info
$155.20
Earnings per share (EPS) forecast
windowbar_chart_4_bars
Actual
info
Expected
info
Surprise
info
-$0.95
-$0.76
-25.00%
Q1 • 25Missed
-$0.89
-$0.95
6.32%
Q2 • 25Beat
-$2.47
-$0.79
-212.66%
Q3 • 25Missed
-$1.18
-$1.04
-13.46%
Q4 • 25Current
QuarterlyAnnual
Financial Performance
windowbar_chart_4_bars
Income StatementBalance SheetCash Flow
windowbar_chart_4_bars
Revenue
info
Net income
info
Profit margin
info
$0M
$-153M
-∞%
Q3 • 25
$-2M
$-222M
11,009.07%
Q4 • 25
-∞%
44.79%
NaN%
QoQ growth
QuarterlyAnnual
Totals assets
info
Total liabilities
info
Debt to assets
info
$652M
$141M
21.60%
Q3 • 25
$584M
$129M
22.10%
Q4 • 25
-10.42%
-8.33%
2.33%
QoQ growth
QuarterlyAnnual
Operating
info
Investing
info
Financing
info
Free cash flow
info
$-71.3M
-
$603M
$-71.3M
Q3 • 25
$-71.3M
-
$603M
$-71.3M
Q4 • 25
-
-
0.00%
-0.00%
QoQ growth
QuarterlyAnnual

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Past performance is no guarantee of future results. Your return may be affected by currency fluctuations and applicable fees and charges. The value of your investment may go up as well as down. When investing, your capital at risk.

Build your future fund today!

Automate your wealth-building journey and turn investing into a habit that your future self will be grateful for!

Capital at risk.

FAQs

How much is a Abivax SA American Depositary Shares share?
Collapse

Abivax SA American Depositary Shares shares are currently traded for undefined per share.

How many shares does Abivax SA American Depositary Shares have?
Collapse

Abivax SA American Depositary Shares currently has 79.3M shares.

Does Abivax SA American Depositary Shares pay dividends?
Collapse

No, Abivax SA American Depositary Shares doesn't pay dividends.

What is Abivax SA American Depositary Shares 52 week high?
Collapse

Abivax SA American Depositary Shares 52 week high is $148.83.

What is Abivax SA American Depositary Shares 52 week low?
Collapse

Abivax SA American Depositary Shares 52 week low is $5.59.

What is the 200-day moving average of Abivax SA American Depositary Shares?
Collapse

Abivax SA American Depositary Shares 200-day moving average is $106.43.

Who is Abivax SA American Depositary Shares CEO?
Collapse

The CEO of Abivax SA American Depositary Shares is Marc M. P. de Garidel M.B.A..

How many employees Abivax SA American Depositary Shares has?
Collapse

Abivax SA American Depositary Shares has 69 employees.

What is the market cap of Abivax SA American Depositary Shares?
Collapse

The market cap of Abivax SA American Depositary Shares is $9.67B.

What is the P/E of Abivax SA American Depositary Shares?
Collapse

The current P/E of Abivax SA American Depositary Shares is null.

What is the EPS of Abivax SA American Depositary Shares?
Collapse

The EPS of Abivax SA American Depositary Shares is -$5.69.

What is the PEG Ratio of Abivax SA American Depositary Shares?
Collapse

The PEG Ratio of Abivax SA American Depositary Shares is null.

What do analysts say about Abivax SA American Depositary Shares?
Collapse

According to the analysts Abivax SA American Depositary Shares is considered a buy.